Abstract:Objectives Our previous studies have shown that interleukin-6 (IL-6) is overexpressed in the saliva of patients with oral lichen planus (OLP) and is positively correlated with severity of disease. IL-6 may be associated with immune imbalance in patients with OLP. The purpose of the present study was to investigate the inhibitory effect of IL-6 on regulatory T cells (Treg) derived from patients with OLP. Study Design The diagnosis of OLP was acquired on the basis of both clinical and pathologic manifestations. Peripheral blood and its cultured supernatants were detected by using cytometric beads assay. The expression of IL-6 in local lesions was detected by using immunohistochemistry. The inhibition effect of OLP-derived or healthy-derived Treg on the proliferation of T effector cells (Teff) was detected by using flow cytometry; The OLP-derived Treg inhibition effect was detected after upregulating or neutralizing IL-6. Results Plasma IL-6 concentration in 31 patients with OLP was 10660.00 ± 7205.00 fg/mL, which was significantly higher than that in the healthy control group (325.70 ± 32.28 fg/mL; n = 11; P < .05). It was also higher in ex vivo cultured supernatants of patient-derived Teff than those of healthy controls (133.60 ± 30.01 μg/mL vs 34.94 ± 11.47 μg/mL; n = 6; P < .05). IL-6 was also overexpressed in local lesions than in healthy controls. In a co-culture experiment, the inhibition rate of OLP-derived Treg against proliferation of autologous Teff was 36.15% ± 4.78%, which was significantly lower than that in the healthy control group by 57.75% ± 6.68% (P < .05; n = 6). When IL-6 was added to healthy-derived Treg, the inhibition rate decreased to 32.92% ± 5.54%; after neutralizing IL-6 in OLP-derived Treg, the inhibition rate went up to 55.32% ± 5.13%. Conclusions IL-6 was elevated in peripheral blood and local lesions in patients with OLP. In vitro, the inhibition effect of Treg on proliferation of autologous Teff in patients with OLP was significantly lower than that in healthy controls. This phenotype could be reversed in vitro when neutralizing IL-6. IL-6 may be an important factor affecting the immune homeostasis in OLP. Our previous studies have shown that interleukin-6 (IL-6) is overexpressed in the saliva of patients with oral lichen planus (OLP) and is positively correlated with severity of disease. IL-6 may be associated with immune imbalance in patients with OLP. The purpose of the present study was to investigate the inhibitory effect of IL-6 on regulatory T cells (Treg) derived from patients with OLP. The diagnosis of OLP was acquired on the basis of both clinical and pathologic manifestations. Peripheral blood and its cultured supernatants were detected by using cytometric beads assay. The expression of IL-6 in local lesions was detected by using immunohistochemistry. The inhibition effect of OLP-derived or healthy-derived Treg on the proliferation of T effector cells (Teff) was detected by using flow cytometry; The OLP-derived Treg inhibition effect was detected after upregulating or neutralizing IL-6. Plasma IL-6 concentration in 31 patients with OLP was 10660.00 ± 7205.00 fg/mL, which was significantly higher than that in the healthy control group (325.70 ± 32.28 fg/mL; n = 11; P < .05). It was also higher in ex vivo cultured supernatants of patient-derived Teff than those of healthy controls (133.60 ± 30.01 μg/mL vs 34.94 ± 11.47 μg/mL; n = 6; P < .05). IL-6 was also overexpressed in local lesions than in healthy controls. In a co-culture experiment, the inhibition rate of OLP-derived Treg against proliferation of autologous Teff was 36.15% ± 4.78%, which was significantly lower than that in the healthy control group by 57.75% ± 6.68% (P < .05; n = 6). When IL-6 was added to healthy-derived Treg, the inhibition rate decreased to 32.92% ± 5.54%; after neutralizing IL-6 in OLP-derived Treg, the inhibition rate went up to 55.32% ± 5.13%. IL-6 was elevated in peripheral blood and local lesions in patients with OLP. In vitro, the inhibition effect of Treg on proliferation of autologous Teff in patients with OLP was significantly lower than that in healthy controls. This phenotype could be reversed in vitro when neutralizing IL-6. IL-6 may be an important factor affecting the immune homeostasis in OLP.

Overexpression and Selectively Regulatory Roles of IL-23/IL-17 Axis in the Lesions of Oral Lichen Planus

Aberrant Expression of Interleukin-22 and Its Targeting Micrornas in Oral Lichen Planus: a Preliminary Study.

Altered Expression of Interleukin-17A and Its Targeting Micrornas in Oral Lichen Planus: a Pilot Study.

Increased Infiltration of CD11 C+/cd123+ Dendritic Cell Subsets and Upregulation of TLR/IFN-α Signaling Participate in Pathogenesis of Oral Lichen Planus.

Immunoexpression of Interleukin-22 and Interleukin-23 in Oral and Cutaneous Lichen Planus Lesions: a Preliminary Study.

Frequently Increased but Functionally Impaired CD4+CD25+ Regulatory T Cells in Patients with Oral Lichen Planus.

Expression of regulatory T cells and Helper T cells 17 in the lesion tissue of oral lichen planus

Analysis of oral microbial community and Th17-associated cytokines in saliva of patients with oral lichen planus

Expression of Foxp3 and interleukin-17 in lichen planus lesions with emphasis on difference in oral and cutaneous variants

Expression of Foxp3 + regulatory T cells in oral lichen planus

Single-cell immune profiling reveals immune responses in oral lichen planus

Enhanced expression of Toll-like receptor 2 in lesional tissues and peripheral blood monocytes of patients with oral lichen planus

Mixed and Inhomogeneous Expression Profile of Th1/Th2 Related Cytokines Detected by Cytometric Bead Array in the Saliva of Patients with Oral Lichen Planus.

Characterizing inducible tertiary lymphoid structures in oral lichen planus: implications for stromal-immune cells interaction and disease severity

Enhanced T-cell Proliferation and IL-6 Secretion Mediated by Overexpression of TRIM21 in Oral Lesions of Patients with Oral Lichen Planus.

Altered expression of CCN1 in oral lichen planus associated with keratinocyte activation and IL-1β, ICAM1 and CCL5 up-regulation.

Identification of Potential Crucial Immune-related Genes and Key Pathways in Oral Lichen Planus

Overexpressed Interleukin-6 Functionally Impaired CD4+CD25+ Regulatory T Cells in Patients with Oral Lichen Planus: an in Vitro Study

Altered expression of CCN1 in oral lichen planus associated with keratinocyte activation and IL-1, ICAM1, and CCL5 up-regulation

Enhanced Proliferation and Interleukin-6 Secretion of T Cells Mediated by Overexpression of TRIM21 in the Oral Lesions of Patients with Oral Lichen Planus

Increased expression of keratin 17 in oral lichen planus and its correlation with disease severity